Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Philips Slumps After Another Blow to Sleep Product Recall
Philips Slumps After Another Blow to Sleep Product Recall
Sanofi to Explore Acquisition of Cancer Drugmaker Mirati
Sanofi to Explore Acquisition of Cancer Drugmaker Mirati
«12»